Loading company…
RevelAi develops generative AI tools for specialty care and chronic condition management.
RevelAi develops a generative AI platform for specialty care, including tools for clinical workflows, triage, documentation and patient communication. Its focus includes conditions such as osteoarthritis, osteoporosis, fragility fractures and low back pain. Founded in 2022, the company is based in Durham, US. It raised USD 3.1 million in Seed funding in June 2025, co-led by Ulu Ventures and Symphonic Capital, with participation from Orthopedic VC and Sand Hill Angels.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in